WebIn the digoxin group, there was a trend toward a decrease in the risk of death attributed to worsening heart failure (risk ratio, 0.88; 95 percent confidence interval, 0.77 to 1.01; P = 0.06 ... WebJan 11, 2016 · typical mortality rates of 15% to 20% occurring around the stage 1 palliation (S1P), and interstage mortality (IM) rates of 10% to 15% in survivors discharged to …
(PDF) Effect of Digoxin on Interstage Outcomes following Stage I ...
WebJan 26, 2016 · Interstage mortality for those not on digoxin was 12.3%, compared to 2.9% among those on digoxin, with an adjusted hazard ratio of 3.5 (95% CI, 1.1–11.7; … WebNov 16, 2012 · Interstage mortality for those not on digoxin was 12.3%, compared to 2.9% among those on digoxin, with an adjusted hazard ratio of 3.5 (95% CI, 1.1–11.7; P=0.04). The number needed to treat to ... bob 93.3 playlist
Impact of Digoxin Use on Interstage Outcomes of Single Ventricle Heart ...
WebMay 4, 2024 · Conclusions This systematic review and meta-analysis suggests that digoxin significantly decreases interstage period mortality with a concurrent significant decrease in weight for age. The odds of arrhythmia or other complications are not significantly different with digoxin based on current data. Competing Interest Statement. The authors have ... WebFeb 23, 2024 · Digoxin use at the time of discharge was the preeminent protective feature against home interstage mortality both by univariate analysis and advanced ML. The protective effect of digoxin for interstage mortality, despite an unclear therapeutic mechanism, has been reported in several studies [ 9 , 17 , 32 ]. WebMar 1, 2024 · Background Infants born with single right ventricle congenital heart disease (SVCHD) physiology, such as hypoplastic left heart syndrome and variants, are at a high risk for death or transplant during the interstage (IS) defined as the period between Stage 1 surgery (aorto-pulmonary shunt with arch reconstruction) and Stage 2 surgery (superior … bob839us purchase for cash now phone number